Small molecules & peptides

PD 153035

Reference standard for [Methoxy-¹¹C]PD 153035

4-(3-Bromphenylamino)-6,7-bis(methoxy)quinazoline; 4-(3-Bromphenylamino)-6,7-dimethylquinazoline; AG 1517; NSC 669364; SU 5271; WHI-P 79

CA index name: 4-Quinazolinamine, N-(3-bromphenyl)-6,7-dimethoxy-

Quality

Research Chemical

Characteristics

Molar mass 360.21

CAS RN [153436-54-5]

Purity ≥ 95 %

  • Yellowish solid

Certificates

CoA: appearance, ¹H NMR spectrum

Literature

Fredriksson A. et al. In vivo evaluation of the biodistribution of ¹¹C-labeled PD153035 in rats without and with neuroblastoma implants Life Sci. 1999, 65, 165–174.

Johnström P. et al. Synthesis of [Methoxy-¹¹C]PD153035, a Selective EGF Receptor Tyrosine Kinase Inhibitor J. Labelled Compd. Radiopharm. 1998, 41, 623–629.

Gibson K.H. et al. Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumour activity of novel quinazolines Bioorg. Med. Chem. Lett. 1997, 7, 2723–2728.

Add to inquiry

Product No.Filling amountQuantity
Product No.: 5210Filling amount: 10 mg
Product No.: 5210

Related products

Product was added